Innovation Pharmaceuticals Inc. (IPIX)
OTCMKTS · Delayed Price · Currency is USD
0.0003
-0.0001 (-25.00%)
May 26, 2026, 9:30 AM EST
IPIX Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
4
Market Cap
158.63K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2023 | - | - | - |
| Jun 30, 2022 | 18.00K | - | - |
| Jun 30, 2021 | - | - | - |
| Jun 30, 2020 | 423.00K | - | - |
| Jun 30, 2019 | - | - | - |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sorrento Therapeutics | 64.27M |
| Aridis Pharmaceuticals | 22.36M |
| EV Biologics | 9.47M |
| Regen BioPharma | 236.56K |
| GB Sciences | 97.24K |
Innovation Pharmaceuticals News
- 2 years ago - Innovation Pharmaceuticals says BeaMed on track to file 510(k) submission - TheFly
- 2 years ago - Innovation Pharmaceuticals Announces New Milestone at BeaMed; On Track to File 510(k) Submission to FDA in Q2 2024 - GlobeNewsWire
- 3 years ago - Innovation Pharmaceuticals Provides Update on U.S. Patent Applications Covering Use of Brilacidin in Inflammatory Bowel Diseases, Coronaviruses and Fungal Diseases - GlobeNewsWire
- 3 years ago - Innovation Pharma Announces BeaMed Technologies Breakthrough in Development of Fiber Optic Probes for StingRay Laser System; Paves Way for Groundbreaking Integration Testing - GlobeNewsWire
- 3 years ago - Innovation Pharmaceuticals Brilacidin antifungal research published - TheFly
- 3 years ago - Innovation Pharmaceuticals Brilacidin Antifungal Research Published in Nature Communications - GlobeNewsWire
- 3 years ago - Innovation Pharmaceuticals announces new antifungal testing of Brilacidin - TheFly
- 3 years ago - Innovation Pharmaceuticals Announces New Antifungal Testing of Brilacidin by NIH/NIAID-Affiliated and Other Academic Researchers - GlobeNewsWire